Guangdong VTR Bio-Tech Co Ltd
300381
Company Profile
Business description
Guangdong VTR Bio-Tech Co Ltd is a China based biotechnology company. It is engaged in the research, development, production, sales and service of biopharmaceuticals, bio-enzyme preparations, microbial preparations, functional additives and green biological manufacturing engineering. The company's products include Wittler tributyrin, temperature glucose oxidase, Mildew, VTR-TH26 glucoamylase, Sorghum specific compound enzyme and others. It sells its products in China, and also exports it to various other countries.
Contact
No. 8, Pingbei 1st Road
Nanping High-tech Industrial Zone
Guangdong Province
Zhuhai519060
CHNT: +86 7568676888
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
1,102
Stocks News & Analysis
stocks
ChatGPT enters the retail space and one company surges
Investors cheer the ability to purchase directly from ChatGPT.
stocks
Alibaba fair value increases by 49%
Stronger-than-expected AI demand internationally and domestically.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,152.80 | 2.60 | -0.03% |
| CAC 40 | 7,880.87 | 10.19 | 0.13% |
| DAX 40 | 23,745.06 | 5.59 | 0.02% |
| Dow JONES (US) | 46,316.07 | 68.78 | 0.15% |
| FTSE 100 | 9,299.84 | 15.01 | 0.16% |
| HKSE | 26,596.90 | 25.98 | -0.10% |
| NASDAQ | 22,591.15 | 107.09 | 0.48% |
| Nikkei 225 | 45,108.11 | 64.36 | 0.14% |
| NZX 50 Index | 13,292.36 | 159.80 | 1.22% |
| S&P 500 | 6,661.21 | 17.51 | 0.26% |
| S&P/ASX 200 | 8,866.00 | 3.30 | -0.04% |
| SSE Composite Index | 3,878.13 | 15.59 | 0.40% |